genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Zymeworks
Bioprocessing
Enhanced Efficacy for Next-Gen Antibody Therapies
John Sterling
-
August 23, 2023
0
Drug Discovery
Daiichi Sankyo Triples Down on Immuno-Oncology Collaboration with Zymeworks
GEN Staff Writer
-
May 15, 2018
0
Cancer
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B Deal
GEN Staff Writer
-
November 13, 2017
0
Drug Discovery
Zymeworks Secures $8.1M to Advance Antibody and Protein Therapeutics
GEN Staff Writer
-
September 22, 2011
0
Scroll Up
Scroll Up
